The FDA granted a Priority Review in February 2024 and was assigned a PDUFA date of August 10, 2024. ATEV is a bioengineered human tissue designed to be a universally implantable vascular conduit for ...

When biomedical researchers need to test their latest ideas, they often turn to engineered human tissue that mimics the responses in our own bodies. It's become an important intermediary step before ...

Boston Children's Hospital scientists have unveiled a five-day approach to generate functional vascular organoids capable of supporting blood flow and in vivo engraftment. Subscribe to our newsletter ...

Paul Stankey (left) is a fourth-year PhD student at Harvard School of Engineering and Applied Sciences and the Wyss Institute (both MA, USA), working in Professor Jennifer Lewis’ lab. Jennifer leads a ...

Study: An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Image Credit: Shit4Sell / Shutterstock.com In a recent study ...

Using postmortem human brain tissue, three-dimensional imaging revealed vascular Aβ deposition patterns and a lower density of parenchymal amyloid plaques surrounding Aβ-positive vessels. Smooth ...

Humacyte, a bioengineering company, went public through a SPAC merger in 2015, with a market value of $1.1 billion. The company has received FDA's RMAT designation for three indications, including ...

Never-before-seen 3D reconstructions of human liver tissue have been created at a cellular level. The details obtained by a team of UW Medicine and University of Washington engineers and physicians ...

A multi-institutional team led by the Chinese Academy of Sciences has constructed a proteomic atlas of human aging across 13 organs, revealing tissue-specific aging clocks, transcriptome-proteome ...